EP
RVMD icon

Edgestream Partners’s Revolution Medicines RVMD Stock Holding History

Edgestream Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.74M Buy
+69,262
New +$6.99M 0.22% 143
2025
Q3 		– Sell
-204,313
Closed -$7.52M – 1034
2025
Q2 		$7.52M Sell
204,313
-11,404
-5% -$438K 0.21% 167
2025
Q1 		$7.63M Buy
215,717
+207,938
+2,673% +$8.44M 0.26% 101
2024
Q4 		$340K Sell
7,779
-30,703
-80% -$1.55M 0.01% 742
2024
Q3 		$1.75M Buy
+38,482
New +$1.68M 0.08% 443

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Edgestream Partners's RVMD Position: Q1 2026 in Review

Edgestream Partners opened a new position in Revolution Medicines (RVMD) in Q1 2026: 69,262 shares worth $6.74M. The stake represents 0.22% of the portfolio and ranks #143 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in RVMD as recently as Q2 2025.

Edgestream Partners first reported a position in RVMD in Q3 2024 and has held it in 5 quarters since. The position peaked at $7.63M in Q1 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Edgestream Partners held 69,262 shares of Revolution Medicines worth $6.74M as of Q1 2026.
  • Revolution Medicines was a new Edgestream Partners position in Q1 2026.
  • Revolution Medicines made up 0.22% of Edgestream Partners's portfolio in Q1 2026, its #143 holding.
  • Edgestream Partners first reported a position in Revolution Medicines in Q3 2024 and has held it in 5 quarters since.
  • Edgestream Partners's Revolution Medicines position peaked at $7.63M in Q1 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.